Form D · Pharmaceuticals
Sirion Holdings, Inc.
Tampa, FL · CIK 0001355015
Offering snapshot reported Oct 27, 2009 · SEC filing
- Reported sold
- $27.7M Offering amount: $66.7M
- Investors reported
- 17 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 15, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 27, 2009 | Initial | $27,684,009 | No comparison | 17 | SEC filing |
| Aug 5, 2009 | Initial | $1,500,001 | No comparison | 1 | SEC filing |
| Feb 24, 2009 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Sep 28, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-95293
Source: Form D, filed Oct 27, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Peter Barrett | Director |
| Susan Benton | Executive |
| Barry Butler | Director, Executive |
| James Butler | Director |
| Charles Cohen | Director |
| Todd Creech | Executive |
| Kevin Kinsella | Director |
| Anthony Maida | Director |
| Liza Page Nelson | Director |
| Thomas Riedhammer | Director |
| Andrew Schiff | Director |
| Roger Vogel | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
9314 East Broadway Avenue
Tampa, FL, 33619
Tampa, FL, 33619